Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00871754 · ClinicalTrials.gov registry record
Molecular Analysis Of Bladder Cancer
A clinical trial of Bladder Cancer and Bladder Neoplasms, sponsored by Lahey Clinic.
- Active
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT00871754: Active study of Bladder Cancer and Bladder Neoplasms, sponsored by Lahey Clinic.
NCT00871754 is a study of Bladder Cancer and Bladder Neoplasms that is active but no longer recruiting, run by Lahey Clinic. The registered enrollment target is 5,000 participants, below the 12,725-participant average among 175 other Bladder Cancer trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00871754, a study of Bladder Cancer and Bladder Neoplasms, is active but no longer recruiting, sponsored by Lahey Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a laboratory study where the investigators hope to look at chromosomal events implicated in bladder cancer.
Conditions Studied
Study Locations (1)
Massachusetts
- Lahey Clinic - Burlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 1988-04 |
| Est. Completion | 2028-12 |
What the registry record for NCT00871754 still lists
NCT00871754 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, below the 12,725-participant average among 175 other Bladder Cancer trials with a reported enrollment target (61% lower).
The record links to 2 conditions, with Bladder Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00871754 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00871754 about?
NCT00871754 is a clinical study titled "Molecular Analysis Of Bladder Cancer". This is a laboratory study where the investigators hope to look at chromosomal events implicated in bladder cancer.
What is the current status of trial NCT00871754?
This trial is currently active not recruiting. The enrollment target is 5,000 participants. The study started on 1988-04. Estimated completion is 2028-12.
What conditions does trial NCT00871754 study?
This clinical trial studies the following conditions: Bladder Cancer, Bladder Neoplasms.
Who is sponsoring clinical trial NCT00871754?
This trial is sponsored by Lahey Clinic, which has 43 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00871754 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bladder Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00871754's enrollment target sits among peer trials
5,000 7th of 175 higher than 169 of 175 other Bladder Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bladder Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
RECRUITING · Phase 1
-
Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy
RECRUITING · NA
-
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
RECRUITING · Phase 1
-
CONFIRM: Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
-
Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia